drugset
drugset / Trial / NCT06308393

Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects

NCT06308393 ↗

Phase 1 Active not recruiting 98 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized, double-blind, placebo-controlled study of RSS0393 ointment in healthy and psoriatic subjects

Timeline

Start
2024-03-01
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject RSS0393 Unknown — Topical

Indications

psoriasis